Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppressive potential of antimalarials.

G Salmeron, P E Lipsky

    The American Journal of Medicine
    |July 18, 1983
    PubMed
    Summary

    Chloroquine phosphate and hydroxychloroquine sulfate may treat rheumatoid arthritis by inhibiting monocyte accessory function and Interleukin-1 secretion. This impacts T cell proliferation and immunoglobulin production in patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A critical review of clinical trials in systemic lupus erythematosus.

    Lupus·2016
    Same author

    Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.

    Lupus·2016
    Same author

    Accessory cells unrelated to mononuclear phagocytes and not of bone marrow origin.

    Immunology today·2014
    Same author

    Interleukin 21 as a target of intervention in autoimmune disease.

    Annals of the rheumatic diseases·2008
    Same author

    Age-related impairment of T cell proliferative responses related to the decline of CD28+ T cell subsets.

    Archives of gerontology and geriatrics·2008
    Same author

    Measurement of human and murine interleukin 2 and interleukin 4.

    Current protocols in immunology·2008

    Area of Science:

    • Immunology
    • Pharmacology
    • Rheumatology

    Background:

    • Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
    • Chloroquine and hydroxychloroquine are established treatments for RA, but their precise mechanisms of action remain incompletely understood.
    • In vitro studies are crucial for elucidating drug mechanisms at the cellular level.

    Purpose of the Study:

    • To investigate the in vitro mechanisms by which chloroquine phosphate and hydroxychloroquine sulfate exert therapeutic effects in rheumatoid arthritis.
    • To correlate drug concentrations with observed cellular effects, ensuring clinical relevance.
    • To provide a mechanistic hypothesis for the efficacy of these drugs in RA patients.

    Main Methods:

    • Human peripheral blood mononuclear cells were cultured and stimulated with various agents.
    • Assays were performed to measure T cell proliferation and immunoglobulin-secreting cell generation.
    • Drug effects on monocyte accessory function and Interleukin-1 secretion were analyzed.

    Main Results:

    • Chloroquine demonstrated a dose-dependent inhibition of tritiated thymidine uptake, indicating interference with T cell proliferation.
    • This inhibition was linked to impaired accessory function of monocytes.
    • Chloroquine selectively inhibited the secretion of Interleukin-1 by monocytes, affecting immunoglobulin production.

    Conclusions:

    • Chloroquine and hydroxychloroquine may exert therapeutic effects in rheumatoid arthritis by modulating monocyte function.
    • Inhibition of monocyte accessory function and Interleukin-1 secretion are potential mechanisms underlying their efficacy.
    • These findings offer a mechanistic basis for the clinical use of chloroquine and hydroxychloroquine in RA treatment.

    Related Experiment Videos